Intellia Therapeutics Cash Flow Statement (2015-2026) | NTLA

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	-68.81M	-71.64M	-79.91M	-143.71M	-97.60M	-103.58M	-104.73M	-99.98M	-119.68M	-118.37M	-127.43M	-101.37M	-126.62M	-132.65M	-125.82M	-112.20M	-102.59M	-104.76M	-92.23M	-95.33M
Depreciation and Depletion (Quarter)
Share-based Compensation (Quarter)	10.61M	15.41M	14.56M	18.49M	23.07M	25.21M	24.63M	27.25M	36.40M	35.35M	35.04M	34.18M	40.86M	39.62M	39.62M	21.84M	22.04M	19.60M	16.74M	13.48M
Gains from Sales and Divestitures (Quarter)	0.03M	0.05M	0.12M	0.05M	0.09M	0.09M	0.15M	0.34M	0.49M	0.60M	0.68M	1.02M	1.21M	1.34M	1.43M	1.51M	1.69M	1.80M	2.08M	1.52M
Gains from Investment Securities (Quarter)		2.44M		0.02M	0.24M	1.40M	66.89M	0.10M	0.57M		-0.17M	0.24M	0.80M	3.33M	-3.02M			0.78M	5.17M	0.73M
Non-cash Items (Quarter)	974.47M	1.98M	130.30M	204.87M	105.93M	2.86M	3.22M	94.80M	83.10M	69.20M	35.92M	27.62M	15.82M	4.10M	0.35M	0.02M	4.18M	4.09M	0.05M	2.46M
Cash from Operations (Quarter)	-52.98M	-65.02M	-54.65M	-79.80M	-85.09M	-78.53M	-89.87M	-109.33M	-90.32M	-101.38M	-93.05M	-120.66M	-58.19M	-84.84M	-85.19M	-148.93M	-99.62M	-76.90M	-69.28M	-117.35M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)	-1.66M	-2.10M	-2.63M	-2.43M	-2.00M	-0.82M	1.25M	4.57M	7.10M	7.92M	-19.59M	5.29M	4.65M	-9.93M		2.28M	1.67M	-1.43M	3.63M	0.54M
Depreciation & Amortization (CF) (Quarter)	1.63M	1.79M	1.89M	1.75M	1.84M	1.95M	2.06M	2.05M	2.17M	2.29M	2.47M	2.50M	2.60M	2.60M	2.60M	2.50M	2.50M	2.40M	2.41M	2.20M
Change in Working Capital
Change in Receivables (Quarter)	1.04M	0.50M	-0.46M	-0.23M	1.05M	1.17M	-0.26M	1.14M	0.15M	1.43M	29.96M	-0.03M	-24.10M	-3.47M	-0.34M	1.99M	0.85M	-0.30M	-1.58M	-0.34M
Change in Account Payables (Quarter)	-1.69M	0.74M	2.40M	-0.06M	-3.65M	-1.62M	0.75M	1.17M	5.12M	-7.71M	3.94M	5.57M	5.35M	-5.55M	1.44M	-1.87M	-2.56M	3.46M	6.96M	-1.42M
Change in Accured Expenses (Quarter)	14.72M	-11.30M	18.43M	-3.72M	3.00M	13.57M	3.07M	-17.39M	4.87M	9.52M	9.03M	-22.40M	1.85M	6.22M	3.95M	-14.41M	0.83M	-0.71M	9.03M	-11.95M
Investing Activities
Capital Expenditures (Quarter)	4.45M	4.54M	2.87M	3.72M	1.69M	4.24M	3.91M	3.83M	4.30M	-6.58M	-0.03M	2.51M	-1.88M	4.17M	-4.22M	0.08M	-0.08M		0.03M	0.08M
Change in Acquisitions & Divestments (Quarter)	73.30M	192.49M	94.61M	93.73M	130.85M	212.80M	210.19M	263.62M	213.05M	213.20M	197.23M	267.96M	277.63M	199.67M	321.65M	178.27M	162.75M	115.94M	94.71M	113.35M
Cash from Investing Activities (Quarter)	33.26M	-399.38M	-159.12M	47.47M	95.34M	47.64M	-30.15M	-122.25M	-34.54M	79.50M	45.94M	5.90M	-24.19M	-7.71M	151.56M	94.33M	106.91M	-0.74M	27.53M	66.31M
Financing Activities
Other financing activities (Quarter)
Change in Capital Stock
Shares Issued (Quarter)	-44.28M	38.90M	-37.84M	400.00M	-386.74M	-12.19M	398.93M	0.76M	0.47M	4.38M	0.99M	1.96M	-0.29M		175.23M		13.70M	1.24M	1.35M	750.00M
Preferred Shares Issued (Quarter)
Misc.
Cash from Financing Activities (Quarter)	7.13M	668.68M	2.28M	47.32M	5.89M	23.98M	505.76M	2.22M	2.52M	19.10M	106.48M	59.99M	41.25M	82.19M	2.32M		14.65M	114.86M	1.98M	33.57M
Change in Cash (Quarter)	-12.59M	204.28M	-211.49M	14.99M	16.15M	-6.91M	385.74M	-229.35M	-122.34M	-2.78M	59.37M	-54.77M	-41.13M	-10.35M	68.69M	-54.60M	21.94M	37.22M	-39.77M	-17.47M
Free Cash Flow (Quarter)	-57.43M	-69.56M	-57.52M	-83.52M	-86.78M	-82.76M	-93.78M	-113.16M	-94.62M	-94.80M	-93.03M	-123.17M	-56.31M	-89.00M	-80.97M	-149.01M	-99.54M	-76.90M	-69.32M	-117.42M
Net Cash Flow (Quarter)	-12.59M	204.28M	-211.49M	14.99M	16.15M	-6.91M	385.74M	-229.35M	-122.34M	-2.78M	59.37M	-54.77M	-41.13M	-10.35M	68.69M	-54.60M	21.94M	37.22M	-39.77M	-17.47M

Research Tools

Intellia Therapeutics Cash Flow Statement (2015-2026) | NTLA

Create an account

Sign In

Reset Password